Purchase Order N6311625P0568
- Not listed
- The U.S. Navy's Bureau of Medicine and Surgery awarded a $98,929.70 firm fixed price purchase order to Illumina, Inc. for one MiSeq i100 Plus System with associated installation and operational qualification services. The contract, with an ultimate completion date of October 14, 2025, supports the Naval Health Research Center in San Diego, California, a military medical research facility. This procurement was conducted as a sole-source award under the authority of 10 U.S.C. 3204(a)(1), with no...
- This is a firm fixed price purchase order awarded by the Bureau of Medicine and Surgery, a defense agency, to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The contract is for the first shipment of MiSeq reagents, with a ceiling value of $130,556.94 and a completion date of September 30, 2024. Illumina has previously received prime contracts and subcontracts from various civilian and defense agencies to provide sequencing instruments, reagents, and associated...
- This firm fixed-price purchase order contract was awarded by the Department of the Navy's Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of sequencing and genomic analysis solutions. The contract, valued at $98,450.40, is to provide the agency with TruSeq Nano DNA Kits and MiSeq Reagent Kit V2 for genomic sequencing and analysis. This appears to be a delivery order under a larger Indefinite Delivery Contract worth up to $3.3 million that supports the Navy's nucleic acid...
- This is a $99,996.96 firm fixed price purchase order contract awarded by the U.S. Navy Bureau of Medicine and Surgery to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis products. The contract is for the delivery of Illumina's RNA Prep with Enrichment kits, MiSeq reagent kits, respiratory virus oligo panels, and DNA/RNA universal dual (UD) indexes to support genomic sequencing and analysis requirements at the Naval Health Research Center in San Diego, California....
- This firm fixed-price purchase order was awarded by the Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents. The $116,503.92 contract is for the delivery of undisclosed sequencing products and services to support the agency's mission. Illumina has an Indefinite Delivery Contract worth up to $3.3 million with the Navy for providing reagents and controls for various Illumina sequencing platforms used by the Naval...
- This is a firm fixed price purchase order contract awarded by the U.S. Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of genetic sequencing equipment and reagents. The $102,361.40 contract is for the provision of NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, sample prep kits, sequencing chips, support plans, maintenance services, and bioinformatics products. This contract is not set aside for any...
- This federal contract award was made by the Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $119,742.91 firm fixed price purchase order is for a MiSeq System, related reagents, and support services to be performed in San Diego, CA. The contract does not have a set-aside designation. The award was made on a sole source basis to Illumina, as the provider of the proprietary...
- This firm fixed-price delivery order was awarded by the Southeast Area of the U.S. Department of the Navy's Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $95,931 award is for the provision of an Illumina MiSeq System, a high-throughput DNA sequencing platform, to support nucleic acid sequencing needs at the Naval Medical Research Center's Biological Defense Research Directorate. This delivery order is part of a...
- This is a firm-fixed-price purchase order contract awarded by the U.S. Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for the provision of one MiSeq System and a 12-month MiSeq Silver Support Plan, valued at $88,357.50. The contract was awarded on a sole-source basis under the authority of 10 U.S.C. 2304(c)(1), as the Naval Health Research Center requires Illumina's proprietary MiSeq technology for their...
- This is a $48,647 firm fixed price purchase order contract awarded by the U.S. Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer and provider of genomic sequencing and analysis solutions. The contract is for the purchase of Illumina's genetic sequencing products, including NextSeq, NovaSeq, MiSeq, and iSeq systems, as well as accompanying reagents, consumables, and support services. This award is part of a larger Indefinite Delivery Contract worth up to $3.3 million that...
The U.S. Navy's Bureau of Medicine and Surgery awarded a $35,668.98 firm fixed price purchase order to Illumina, Inc. on September 10, 2025, for reagents and supplies supporting the Illumina MiSeq Sequencing System at the Naval Health Research Center in San Diego, California. The contract, which utilizes no set-aside designation, procures three specific laboratory products essential for DNA sequencing operations: Illumina Respiratory Virus Enrichment Kit Set A (3 units), MiSeq Reagent Nano Kit v2 (3 units), and PhiX Control v3 (2 units), with scheduled deliveries spanning September 2025 through April 2026. This procurement was conducted as a sole-source award under the authority of 10 U.S.C. 3204(a)(1), reflecting Illumina's specialized technological capabilities in genomic sequencing platforms and consumables. The award supports the Naval Health Research Center's analytical laboratory operations for medical research and diagnostic capabilities, particularly in respiratory virus detection and analysis. Illumina, Inc., a biotechnology company headquartered in San Diego and specializing in genetic sequencing and genomic analysis technologies, has established itself as a critical supplier to multiple federal agencies across civilian and defense sectors. The contract carries an ultimate completion date of October 1, 2025, and represents a continuation of the Navy's ongoing operational requirements for advanced sequencing reagents and supplies to support its medical research and diagnostic missions.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Reagents and Supplies for Illumina MiSeq Sequencing System | N63116-25-Q-0568 | Department of the Navy Naval Supply Systems Command | Special Notice 1/1 | 8/5/25, 4:56 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $35.7k | 9/9/25 |